The Expanded Endocannabinoid System/Endocannabinoidome as a Potential Target for Treating Diabetes Mellitus
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Expanded Endocannabinoid System/Endocannabinoidome as a Potential Target for Treating Diabetes Mellitus
Authors
Keywords
-
Journal
Current Diabetes Reports
Volume 19, Issue 11, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-05
DOI
10.1007/s11892-019-1248-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High Fat Diet Increases Circulating Endocannabinoids Accompanied by Increased Synthesis Enzymes in Adipose Tissue
- (2019) Eline N. Kuipers et al. Frontiers in Physiology
- Intestinal epithelial N-acylphosphatidylethanolamine phospholipase D links dietary fat to metabolic adaptations in obesity and steatosis
- (2019) Amandine Everard et al. Nature Communications
- Endocannabinoids in Islets of Langerhans: The Ugly, the Bad and the Good Facts
- (2018) Isabel González-Mariscal et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Plasma endocannabinoid levels in lean, overweight and obese humans: relationships with intestinal permeability markers, inflammation and incretin secretion
- (2018) Tanya J. Little et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The therapeutic potential of targeting the peripheral endocannabinoid/CB 1 receptor system
- (2018) Joseph Tam et al. European Journal of Internal Medicine
- Lysophosphatidylinositols, from Cell Membrane Constituents to GPR55 Ligands
- (2018) Mireille Alhouayek et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Comparing olive oil and C4-dietary oil, a prodrug for the GPR119 agonist, 2-oleoyl glycerol, less energy intake of the latter is needed to stimulate incretin hormone secretion in overweight subjects with type 2 diabetes
- (2018) Mette Johannsen Mandøe et al. Nutrition & Diabetes
- Caloric restriction lowers endocannabinoid tonus and improves cardiac function in type 2 diabetes
- (2018) Huub J. van Eyk et al. Nutrition & Diabetes
- Peripheral CB1 Receptor Neutral Antagonist, AM6545, Ameliorates Hypometabolic Obesity and Improves Adipokine Secretion in Monosodium Glutamate Induced Obese Mice
- (2018) Haiming Ma et al. Frontiers in Pharmacology
- Profiling plasma N-Acylethanolamine levels and their ratios as a biomarker of obesity and dysmetabolism
- (2018) Flaminia Fanelli et al. Molecular Metabolism
- GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues
- (2018) Christopher Lipina et al. FASEB JOURNAL
- New approaches and challenges to targeting the endocannabinoid system
- (2018) Vincenzo Di Marzo NATURE REVIEWS DRUG DISCOVERY
- Cannabinoid receptor type-1 partially mediates metabolic endotoxemia-induced inflammation and insulin resistance
- (2018) Zachary I. Grunewald et al. PHYSIOLOGY & BEHAVIOR
- The role of CB1 in intestinal permeability and inflammation
- (2017) Mustafa A. Karwad et al. FASEB JOURNAL
- Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARα
- (2017) Mustafa A. Karwad et al. FASEB JOURNAL
- PPARγ Modulates Long Chain Fatty Acid Processing in the Intestinal Epithelium
- (2017) Kalina Duszka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Adipocyte cannabinoid receptor CB1 regulates energy homeostasis and alternatively activated macrophages
- (2017) Inigo Ruiz de Azua et al. JOURNAL OF CLINICAL INVESTIGATION
- Probiotics, prebiotics, synbiotics and insulin sensitivity
- (2017) Y. A. Kim et al. NUTRITION RESEARCH REVIEWS
- Endocannabinoid system acts as a regulator of immune homeostasis in the gut
- (2017) Nandini Acharya et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dietary Capsaicin Improves Glucose Homeostasis and Alters the Gut Microbiota in Obese Diabetic ob/ob Mice
- (2017) Jun-Xian Song et al. Frontiers in Physiology
- Decreasing CB 1 receptor signaling in Kupffer cells improves insulin sensitivity in obese mice
- (2017) Tony Jourdan et al. Molecular Metabolism
- Plasma 2-arachidonoylglycerol is a biomarker of age and menopause related insulin resistance and dyslipidemia in lean but not in obese men and women
- (2017) Flaminia Fanelli et al. Molecular Metabolism
- The cannabinoid ligand LH-21 reduces anxiety and improves glucose handling in diet-induced obese pre-diabetic mice
- (2017) Silvana Y. Romero-Zerbo et al. Scientific Reports
- Early Low-Fat Diet Enriched With Linolenic Acid Reduces Liver Endocannabinoid Tone and Improves Late Glycemic Control After a High-Fat Diet Challenge in Mice
- (2016) Laurent Demizieux et al. DIABETES
- Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study
- (2016) Khalid A. Jadoon et al. DIABETES CARE
- Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice
- (2016) Aine M. McKillop et al. DIABETOLOGIA
- GPR119: a promising target for nonalcoholic fatty liver disease
- (2016) Jin Won Yang et al. FASEB JOURNAL
- PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD
- (2016) Barbara Gross et al. Nature Reviews Endocrinology
- Serum levels of endocannabinoids are independently associated with nonalcoholic fatty liver disease
- (2016) Shira Zelber-Sagi et al. Obesity
- Human CB1 Receptor Isoforms, present in Hepatocytes and β-cells, are Involved in Regulating Metabolism
- (2016) Isabel González-Mariscal et al. Scientific Reports
- The metabolic effects of a commercially available chicken peri-peri (African bird’s eye chilli) meal in overweight individuals
- (2015) Jacolene Kroff et al. BRITISH JOURNAL OF NUTRITION
- Role of the endocannabinoid system in diabetes and diabetic complications
- (2015) G Gruden et al. BRITISH JOURNAL OF PHARMACOLOGY
- Transient receptor potential vanilloid type-1 channel regulates diet-induced obesity, insulin resistance, and leptin resistance
- (2015) Eunjung Lee et al. FASEB JOURNAL
- Deletion of G-protein-coupled receptor 55 promotes obesity by reducing physical activity
- (2015) A Meadows et al. INTERNATIONAL JOURNAL OF OBESITY
- G Protein-Coupled Receptor 119 (GPR119) Agonists for the Treatment of Diabetes: Recent Progress and Prevailing Challenges
- (2015) Kurt Ritter et al. JOURNAL OF MEDICINAL CHEMISTRY
- Effect of oleoylethanolamide on diet-induced nonalcoholic fatty liver in rats
- (2015) Long Li et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Fetal endocannabinoids orchestrate the organization of pancreatic islet microarchitecture
- (2015) Katarzyna Malenczyk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Polypharmacology Shakes Hands with Complex Aetiopathology
- (2015) James S. Brodie et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Adipose tissue NAPE-PLD controls fat mass development by altering the browning process and gut microbiota
- (2015) Lucie Geurts et al. Nature Communications
- Changes in Plasma Levels of N-Arachidonoyl Ethanolamine and N-Palmitoylethanolamine following Bariatric Surgery in Morbidly Obese Females with Impaired Glucose Homeostasis
- (2015) Akhila Mallipedhi et al. Journal of Diabetes Research
- Circulating Endocannabinoids and the Polymorphism 385C>A in Fatty Acid Amide Hydrolase (FAAH) Gene May Identify the Obesity Phenotype Related to Cardiometabolic Risk: A Study Conducted in a Brazilian Population of Complex Interethnic Admixture
- (2015) Cyro José de Moraes Martins et al. PLoS One
- Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB1receptors and TRPV1 channels
- (2014) Raffaele Capasso et al. BRITISH JOURNAL OF PHARMACOLOGY
- Acute Activation of Cannabinoid Receptors by Anandamide Reduces Gastrointestinal Motility and Improves Postprandial Glycemia in Mice
- (2014) Stephanie Troy-Fioramonti et al. DIABETES
- The Impact of Marijuana Use on Glucose, Insulin, and Insulin Resistance among US Adults
- (2013) Elizabeth A. Penner et al. AMERICAN JOURNAL OF MEDICINE
- Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice
- (2013) A M McKillop et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Endocannabinoid System in Energy Homeostasis and the Etiopathology of Metabolic Disorders
- (2013) Cristoforo Silvestri et al. Cell Metabolism
- Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation
- (2013) Giuseppe Esposito et al. GUT
- Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasingde novosynthesis of long-chain ceramides
- (2013) Resat Cinar et al. HEPATOLOGY
- Gut metagenome in European women with normal, impaired and diabetic glucose control
- (2013) Fredrik H. Karlsson et al. NATURE
- Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes
- (2013) Tony Jourdan et al. NATURE MEDICINE
- Circulating endocannabinoids in insulin sensitive vs. Insulin resistant obese postmenopausal women. A MONET group study
- (2013) Joseph Abdulnour et al. Obesity
- Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
- (2013) A. Everard et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The cannabinoid Δ9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity
- (2013) E T Wargent et al. Nutrition & Diabetes
- Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance
- (2012) Joseph Tam et al. Cell Metabolism
- Expression and Function of Monoacylglycerol Lipase in Mouse ß-cells and Human Islets of Langerhans
- (2012) Chen Li et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Transient Receptor Potential Vanilloid 1 Activation Enhances Gut Glucagon-Like Peptide-1 Secretion and Improves Glucose Homeostasis
- (2012) P. Wang et al. DIABETES
- Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders
- (2012) Cristoforo Silvestri et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The therapeutic potential of GPR119 agonists for type 2 diabetes
- (2012) Takahide Ohishi et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Hepatic Cannabinoid Receptor-1 Mediates Diet-Induced Insulin Resistance via Inhibition of Insulin Signaling and Clearance in Mice
- (2012) Jie Liu et al. GASTROENTEROLOGY
- The Cannabinoid Receptor CB1 Modulates the Signaling Properties of the Lysophosphatidylinositol Receptor GPR55
- (2012) Julia Kargl et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A metagenome-wide association study of gut microbiota in type 2 diabetes
- (2012) Junjie Qin et al. NATURE
- Type 2 Diabetes Associated Changes in the Plasma Non-Esterified Fatty Acids, Oxylipins and Endocannabinoids
- (2012) Dmitry Grapov et al. PLoS One
- Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability
- (2011) A Alhamoruni et al. BRITISH JOURNAL OF PHARMACOLOGY
- The L- -Lysophosphatidylinositol/GPR55 System and Its Potential Role in Human Obesity
- (2011) J. M. Moreno-Navarrete et al. DIABETES
- Cannabinoids Inhibit Insulin Receptor Signaling in Pancreatic -Cells
- (2011) W. Kim et al. DIABETES
- Cannabinoid Receptor Type 1 (CB1R) Signaling Regulates Hepatic Gluconeogenesis via Induction of Endoplasmic Reticulum-bound Transcription Factor cAMP-responsive Element-binding Protein H (CREBH) in Primary Hepatocytes
- (2011) Dipanjan Chanda et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- 2-Oleoyl Glycerol Is a GPR119 Agonist and Signals GLP-1 Release in Humans
- (2011) Katrine B. Hansen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans
- (2011) Silvana Y Romero-Zerbo et al. JOURNAL OF ENDOCRINOLOGY
- Dietary Capsaicin Attenuates Metabolic Dysregulation in Genetically Obese Diabetic Mice
- (2011) Ji-Hye Kang et al. JOURNAL OF MEDICINAL FOOD
- A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents
- (2011) X.-H. Lin et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice
- (2011) Fabiana Piscitelli et al. Nutrition & Metabolism
- Altered Gut Microbiota and Endocannabinoid System Tone in Obese and Diabetic Leptin-Resistant Mice: Impact on Apelin Regulation in Adipose Tissue
- (2011) Lucie Geurts et al. Frontiers in Microbiology
- GPR55: Current Knowledge and Future Perspectives of a Purported “Type-3” Cannabinoid Receptor
- (2010) A. Moriconi et al. CURRENT MEDICINAL CHEMISTRY
- A “Cute” Desensitization of TRPV1
- (2010) Filip Touska et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Cannabinoid Receptor Stimulation Impairs Mitochondrial Biogenesis in Mouse White Adipose Tissue, Muscle, and Liver: The Role of eNOS, p38 MAPK, and AMPK Pathways
- (2010) L. Tedesco et al. DIABETES
- CB1 Antagonism Exerts Specific Molecular Effects on Visceral and Subcutaneous Fat and Reverses Liver Steatosis in Diet-Induced Obese Mice
- (2010) T. Jourdan et al. DIABETES
- Effects of in vitro antagonism of endocannabinoid-1 receptors on the glucose transport system in normal and insulin-resistant rat skeletal muscle
- (2010) K. A. Lindborg et al. DIABETES OBESITY & METABOLISM
- Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age
- (2010) J. Agudo et al. DIABETOLOGIA
- Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
- (2010) Joseph Tam et al. JOURNAL OF CLINICAL INVESTIGATION
- Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a Peripherally Restricted Cannabinoid CB1/CB2 Receptor Agonist, Inhibits Gastrointestinal Motility but Has No Effect on Experimental Colitis in Mice
- (2010) N. L. Cluny et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The endocannabinoid system links gut microbiota to adipogenesis
- (2010) Giulio G Muccioli et al. Molecular Systems Biology
- The neutral cannabinoid CB1 receptor antagonist AM4113 regulates body weight through changes in energy intake in the rat
- (2010) Nina L. Cluny et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- GPR119 Is Essential for Oleoylethanolamide-Induced Glucagon-Like Peptide-1 Secretion From the Intestinal Enteroendocrine L-Cell
- (2009) L. M. Lauffer et al. DIABETES
- Beneficial effect of a chronic treatment with rimonabant on pancreatic function and β-cell morphology in Zucker Fatty rats
- (2009) Valérie F. Duvivier et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Dietary Capsaicin Reduces Obesity-induced Insulin Resistance and Hepatic Steatosis in Obese Mice Fed a High-fat Diet
- (2009) Ji-Hye Kang et al. Obesity
- Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis
- (2009) Vanessa Deveaux et al. PLoS One
- Targeted enhancement of oleoylethanolamide production in proximal small intestine induces across-meal satiety in rats
- (2008) Jin Fu et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet
- (2008) V Di Marzo et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Lipid Messenger OEA Links Dietary Fat Intake to Satiety
- (2008) Gary J. Schwartz et al. Cell Metabolism
- Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors
- (2008) V. Di Marzo et al. DIABETOLOGIA
- Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle
- (2008) K. Eckardt et al. DIABETOLOGIA
- Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice
- (2008) Douglas Osei-Hyiaman et al. JOURNAL OF CLINICAL INVESTIGATION
- Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets
- (2008) Isabel Matias et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started